Exclusive: as evidence emerges that schizophrenia could be an immune system disease, two-year trial will use antibody drug currently used for MSBritish scientists have begun testing a radically new approach to treating schizophrenia based on emerging evidence that it could be a disease of the immune system. “The mind and body interact constantly and the immune system is no different. But in schizophrenia patients, the pruning appears to become more aggressive, leading to vital connections being lost. And although the diseases manifest in very different ways, apparent parallels in the underlying biology raise the possibility that the MS drug might help schizophrenia patients. “There’s a lot of emerging evidence that the immune system is going wrong [in schizophrenia],” she said.

Source: The Guardian November 03, 2017 15:52 UTC